Philippines

Participating institutions

  • De La Salle Medical and Health Sciences Institute (DLSMHSI)
  • Research Institute for Tropical Medicine (RITM-NTRL)
  • University of the Philippines Manila (UP-NIH)

Lead investigator

  • Charles Yu, MD, MSc (DLSMHSI)

Co-investigators

  • Ramon Basilio, MD (RITM-NTRL)
  • Victoria Dalay, MD (DLSMHSI)
  • Raul Destura, MD (UP-NIH)
  • Dodge Lim (RITM-NTRL)
  • Roeus Vincent Arjay Reyes (RITM-NTRL)

Staff

  • Danaida (Naida) Marcelo, Study Coordinator
  • Joseph Edwin Bascuna (NTRL), Medical Technologist
  • Gabriela Castillon, Study Nurse
  • Camille Felizardo, Medical Technologist
  • Mary Faith Franco, Medical Technologist
  • Eleonor Garcia, Research Assistant
  • Maria Marissa Golla, Medical officer
  • Janine Ikan, Research Assistant for DCE Substudy
  • Leonedy Masangcay, Medical Technologist
  • Angelita Pabruada, Senior Medical Technician
  • Laarean Perlas, Study Nurse
  • Maria Guileane Pogosa (NTRL), Medical Technologist
  • Annalyn (Anna) Reyes, Quality officer
  • Maricef (Mariz) Tonquin, Finance officer
  • Cherry Ann Villarin, Research Assistant/Medical Technologist

  • As of April 2024

Cohort enrollment capacity

  • Adults with presumptive TB
  • Children with presumptive TB
  • People with diabetes
  • Drug-resistant TB
Estimates of TB burden, 2022
Number Rate per 100,000 population
Total TB incidence 737,000 (390,000 – 1,220,000) 638 (337 – 1060)
HIV-positive TB incidence 14,000 (5,600 – 27,000) 12 (4.8 – 23)
MDR/RR-TB incidence 31,000 (12,000 – 49,000) 27 (11 – 43)
HIV-negative TB mortality 39,000 (36,000 – 43,000) 34 (31 – 37)
HIV-positive TB mortality 800 (730 - 860) 0.69 (0.63 – 0.75)

Full WHO TB country profile